Nutrien (NYSE:NTR) issued its quarterly earnings results on Sunday. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.20, MarketWatch Earnings reports. The company had revenue of $4.66 billion for the quarter, compared to analyst estimates of $4.37 billion. Nutrien had a return on equity of 4.19% and a net margin of 0.47%. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.12) EPS.
Shares of NYSE:NTR traded up $2.39 during mid-day trading on Tuesday, hitting $58.35. 3,388,205 shares of the company traded hands, compared to its average volume of 1,995,853. The firm’s 50 day simple moving average is $55.44 and its 200 day simple moving average is $50.75. The firm has a market cap of $33.27 billion, a P/E ratio of 342.53, a PEG ratio of 3.01 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.85 and a current ratio of 1.39. Nutrien has a 52-week low of $29.70 and a 52-week high of $59.76.
The business also recently announced a quarterly dividend, which was paid on Thursday, April 15th. Stockholders of record on Wednesday, March 31st were given a $0.46 dividend. This is an increase from Nutrien’s previous quarterly dividend of $0.35. The ex-dividend date was Tuesday, March 30th. This represents a $1.84 annualized dividend and a dividend yield of 3.15%. Nutrien’s dividend payout ratio is presently 82.95%.
Several research firms recently weighed in on NTR. Royal Bank of Canada increased their target price on Nutrien from $60.00 to $62.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 14th. Atlantic Securities cut shares of Nutrien from a “neutral” rating to an “underweight” rating in a research report on Tuesday, January 12th. Zacks Investment Research downgraded shares of Nutrien from a “strong-buy” rating to a “hold” rating in a report on Monday, April 12th. Credit Suisse Group increased their price target on shares of Nutrien from $51.00 to $53.00 and gave the stock a “neutral” rating in a research note on Thursday, February 25th. Finally, Morgan Stanley boosted their price objective on shares of Nutrien from $50.00 to $56.00 and gave the company an “equal weight” rating in a research note on Monday, February 8th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Nutrien has a consensus rating of “Buy” and a consensus price target of $57.50.
Nutrien Company Profile
Nutrien Ltd. provides crop inputs, services, and solutions. The company offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia.
Read More: Retained Earnings
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.